人福医药：关于普瑞巴林缓释片获得药物临床试验批准通知书的公告

Core Viewpoint - The announcement indicates that the company’s subsidiary has received approval for a clinical trial of a new drug, which could enhance its product pipeline and market position in the pharmaceutical industry [1] Group 1 - The company, Renfu Pharmaceutical, announced that its subsidiary, Yichang Renfu Pharmaceutical Co., Ltd., has received a clinical trial approval notice from the National Medical Products Administration for the drug Pregabalin sustained-release tablets [1]